Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
As in 2022, sleep aids was registering a slight decline in current value terms as a result of falling in 2023. While prices were still rising during the pandemic (2020, 2021), which, paired with increased volume demand for sleep aids during the…
Demand for sleep aids remains high in 2023. Since the pandemic, an increase in sleep issues due to anxiety, depression, and stress, has spread among a large proportion of the French population. According to Euromonitor International’s Voice of the…
Sleep aids sales are set to see continued growth in 2023. The major disruptions to lifestyles and the increasing economic pressures experienced in the last few years have led to a significant increase in the incidence of stress and anxiety and…
Sleeping pills are in high demand in Egypt, leading to double-digit retail value growth in 2023. Sleep problems are very common in the country, with many people struggling to fall asleep or stay asleep, impacting their daily lives. Sleeping pills can…
Sleep aids is expected to register moderate current value growth and a slight increase in volume sales in 2023. The war in Ukraine and the resulting energy crisis are pushing up average retail prices. While Danes are now much less concerned about the…
Sleep disorders have increased in Colombia since the pandemic due to the increased incidence of mental health issues and anxiety, whether diagnosed or not. The country still faces barriers to timely attention and diagnosis of psychological and…
Sleep disorders were already in the spotlight after the outbreak of COVID-19, and demand for sleep aids rose, given the disruption to daily routines, coupled with long screen hours during the lockdowns. However, despite the easing of COVID-19…
Demand for sleep aids is growing in 2023 to remain significantly above pre-pandemic levels. Although value growth can also be considered healthy, it falls short when compared to the remarkable figures observed in 2021, when the category experienced…
Sleep aids is projected to post fast retail volume growth over 2023. The category saw spikes in demand in 2020 and 2021 as the stress and anxiety of the Coronavirus (COVID-19) pandemic increased the incidence of sleep disorders or complaints. While…
The demands of busy and stressful lifestyles in Bulgaria have given rise to a significant increase in the demand for sleep aids. As modern life becomes increasingly fast-paced and work-related pressures intensify, many individuals find themselves…
Sleep aids is set to maintain dynamic retail volume growth and even stronger current value growth in Brazil in 2023. For many people, especially those in busy cities, getting a full eight hours sleep each night can feel like a luxury. The fast pace…
Sales of sleep aids are seeing more stable growth in 2023 after the peaks achieved in 2020-2021 when the pandemic created widespread anxiety and insomnia. Many people had to work from home and home-school their children during times of lockdown and…
Retail volume sales of sleep aids are declining for the second year running in 2023. The outbreak of COVID-19 led to increased levels of fear and anxiety in 2020 and 2021 which helped drive record sales of sleep aids. With conditions improving in…
Australian consumers have become increasingly aware of the need for high-quality sleep to improve their overall health. With sleep experts recommending over seven hours of sleep for adults for the best result, consumers are searching for ways to not…
During 2023, sleep aids continued to benefit from the post- pandemic landscape of ongoing global economic instability, compounded by rampant inflation, which placed pressure on both middle- and low-income groups. As a result, consumers were forced to…
Sanofi maintained fourth position in consumer health in 2022 , with its strong brands in analgesics and cough cold and allergy remedies positively affected by growing self-treatment during the pandemic and cold season. The ongoing strategic divesture…
New business models, channels and shopper expectations continue to change retail, redefining industry rules and relationships and disrupting the path to purchase. This content provides strategies for adapting to these shifts and offers a framework to…
Reckitt Benckiser (RB) has strengthened its position in 2022, gaining a place to become the world’s sixth largest consumer health company driven by strong performance in the US and the UK. Growth has been driven by brand development and customer…
Procter & Gamble has maintained its position in 2022. Growth has been driven by persistent consumer loyalty to well-known brands such as Vicks, Metamucil, Align and Neurobion. While North America is a key region, Western Europe and Latin America have…
In Western Europe, the preventative health trend was accelerated by consumers’ rising health concerns due to the 2020 global pandemic. This resulted in several product launches positioned under the immune boost and/or wellbeing umbrellas. This report…